Modeling population pharmacokinetics of lidocaine: Should cardiac output be included as a patient factor?

Anesthesiology

Volumn 94, Issue 4, 2001, Pages 566-573

  Kuipers, Jette A ^a   Boer, Fred ^a   De Roode, Annemiek ^a   Olofsen, Erik ^a   Bovill, James G ^a   Burm, Anton G L ^a,b  

^a Department of Anesthesiology ^*

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LIDOCAINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; FEMALE; HEART OUTPUT; HUMAN; MALE; PRIORITY JOURNAL; RADIAL ARTERY;

EID: 0035094883     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200104000-00007     Document Type: Article

References (30)

1. Population based pharmacokinetic analysis: Why do we need it; what is it; and what has it told us about anaesthetics?
2. Pharmacokinetics and pharmacodynamics: What is of value to the practising anaesthetist?
3. The relationship between alfentanil distribution kinetics and cardiac output
4. Disposition of a flow-limited drug (lidocaine) and a metabolic capacity-limited drug (theophylline) in liver cirrhosis
5. Blood volume measurement at the bedside using ICG pulse spectrophotometry
6. Cardiac output and circulating blood volume analysis by pulse dye-densitometry
7. Multicenter trial of a new thoracic electrical bioimpedance device for cardiac output estimations
8. Clinical evaluation of a new noninvasive method of cardiac output measurement: Preliminary results in CABG patients
9. How many patients and blood levels are necessary for population pharmacokinetic analysis?
10. Pharmacokinetics of lidocaine and bupivacaine and stable isotope labelled analogues: A study in healthy volunteers
11. Measuring the predictive performance of computer-controlled infusion pumps
12. Influence of cardiac output, injection time and injection volume on the initial mixing of drugs with venous blood after i.v. bolus administration to sheep
13. Application of physiologic models to predict the influence of changes in body composition and blood flows on the pharmacokinetics of fentanyl and alfentanil in patients
14. The hybrid model: A new pharmacokinetic model for computer-controlled infusion pumps
15. The pharmacokinetics of lignocaine in humans during a computer-controlled infusion
16. Disposition kinetics of lidocaine in normal subjects
17. Lidocaine disposition kinetics in monkey and man. I. Prediction by a perfusion model
18. Rapid prediction of individual dosage requirements for lignocaine
19. Determinants of thiopental induction dose requirements
20. Computer simulation of the effect of alterations in blood flows and body composition on thiopental pharmacokinetics in humans
21. The effect of gender on left ventricular function immediately after the wingate test
22. 2 relationships during submaximal cycle ergometry
23. Changes in cardiac output with age
24. Effect of age on cadiac index, stroke index and left ventricular ejection fraction at rest and during exercise as studied by radiocardiography
25. Exercise cardiac output is maintained with advancing age in healthy human subjects: Cardiac dilatation and increased stroke volume compensate for a diminished heart rate
26. Pharmacokinetic and pharmaco-dynamic principles of drug therapy in old age. Part I
27. Lung uptake of lidocaine in healthy volunteers
28. Lung uptake of lidocaine in man as influenced by anaesthesia, mepivacaine infusion or lung insufficiency
29. Potential pitfalls in the conventional pharmacokinetic studies: Effects of the initial mixing of drug in blood and the pulmonary first-pass elimination